MaxCyte (MXCT) stock dips as the company agrees to buy Akron BioProducts for $151.8M in cash and stock. Read more here.
Gainers MaxCyte (NASDAQ:MXCT) shares rose 34.5% to $1.3 during Wednesday's regular session. The company's market cap stands at $102.6 million. Liquidia (NASDAQ:LQDA) stock moved upwards by 26.29% to $33.86.
Detailed price information for Maxcyte Inc (MXCT-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.